Blood cell counts can predict adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis

BACKGROUND: Cancer is concerning owing to its high mortality rate. Consequently, methods of prolonging the life of patients with cancer have become the primary focus of attention research. In recent years, immune checkpoint inhibitors (ICIs) have achieved good clinical efficacy as antitumor drugs; h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Juyue, Du, Zhonghai, Fu, Jie, Yi, Xiuxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029759/
https://www.ncbi.nlm.nih.gov/pubmed/36960068
http://dx.doi.org/10.3389/fimmu.2023.1117447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029759/
https://www.ncbi.nlm.nih.gov/pubmed/36960068
http://dx.doi.org/10.3389/fimmu.2023.1117447

Ejemplares similares